Literature DB >> 17539961

Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia.

Souya Nunobe1, Yukihiro Nakanishi, Hirokazu Taniguchi, Mitsuru Sasako, Takeshi Sano, Hoichi Kato, Hisakazu Yamagishi, Shigeki Sekine, Tadakazu Shimoda.   

Abstract

It is still uncertain whether intestinal metaplasia (IM) of the esophagogastric junction (EGJ) plays a role in the development of adenocarcinoma of the esophagogastric junction (AEGJ). The purpose of the present study was to clarify the relationship between AEGJ and IM in Japanese patients. Forty-eight AEGJ, <3 cm and centered within 1 cm of the EGJ, were investigated. The frequency of IM around AEGJ and the correlation between IM and clinicopathological features were examined. IM was present in the surrounding mucosa in 22 of 48 cases (46%), and was seen more frequently in older patients (P = 0.008). Lymph node metastasis was observed only in cases in which the tumors were not associated with IM (P = 0.017). The gastric phenotype was seen almost exclusively in the group without IM, while the intestinal phenotype was predominant in the group with IM (P = 0.003). The present study found a lower incidence of associated IM than Western studies, and there were significant differences in clinicopathological features between AEGJ with and without IM. It is suggested that AEGJ may develop via two distinct pathways in Japanese patients: IM-related and IM-unrelated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17539961     DOI: 10.1111/j.1440-1827.2007.02102.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  8 in total

1.  Clinicopathological features of Siewert type II adenocarcinoma: comparison of gastric cardia adenocarcinoma and Barrett's esophageal adenocarcinoma following endoscopic submucosal dissection.

Authors:  Hiroki Osumi; Junko Fujisaki; Masami Omae; Tomoki Shimizu; Toshiyuki Yoshio; Akiyoshi Ishiyama; Toshiaki Hirasawa; Tomohiro Tsuchida; Yorimasa Yamamoto; Hiroshi Kawachi; Noriko Yamamoto; Masahiro Igarashi
Journal:  Gastric Cancer       Date:  2016-10-25       Impact factor: 7.370

2.  Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction.

Authors:  Kentaro Sugano; Stuart Jon Spechler; Emad M El-Omar; Kenneth E L McColl; Kaiyo Takubo; Takuji Gotoda; Mitsuhiro Fujishiro; Katsunori Iijima; Haruhiro Inoue; Takashi Kawai; Yoshikazu Kinoshita; Hiroto Miwa; Ken-Ichi Mukaisho; Kazunari Murakami; Yasuyuki Seto; Hisao Tajiri; Shobna Bhatia; Myung-Gyu Choi; Rebecca C Fitzgerald; Kwong Ming Fock; Khean-Lee Goh; Khek Yu Ho; Varocha Mahachai; Maria O'Donovan; Robert Odze; Richard Peek; Massimo Rugge; Prateek Sharma; Jose D Sollano; Michael Vieth; Justin Wu; Ming-Shiang Wu; Duowu Zou; Michio Kaminishi; Peter Malfertheiner
Journal:  Gut       Date:  2022-06-20       Impact factor: 31.793

Review 3.  Histology of Barrett's Metaplasia: Do Goblet Cells Matter?

Authors:  Robert Odze
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

Review 4.  BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.

Authors:  Cathy Bennett; Paul Moayyedi; Douglas A Corley; John DeCaestecker; Yngve Falck-Ytter; Gary Falk; Nimish Vakil; Scott Sanders; Michael Vieth; John Inadomi; David Aldulaimi; Khek-Yu Ho; Robert Odze; Stephen J Meltzer; Eamonn Quigley; Stuart Gittens; Peter Watson; Giovanni Zaninotto; Prasad G Iyer; Leo Alexandre; Yeng Ang; James Callaghan; Rebecca Harrison; Rajvinder Singh; Pradeep Bhandari; Raf Bisschops; Bita Geramizadeh; Philip Kaye; Sheila Krishnadath; M Brian Fennerty; Hendrik Manner; Katie S Nason; Oliver Pech; Vani Konda; Krish Ragunath; Imdadur Rahman; Yvonne Romero; Richard Sampliner; Peter D Siersema; Jan Tack; Tony C K Tham; Nigel Trudgill; David S Weinberg; Jean Wang; Kenneth Wang; Jennie Y Y Wong; Stephen Attwood; Peter Malfertheiner; David MacDonald; Hugh Barr; Mark K Ferguson; Janusz Jankowski
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

5.  Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.

Authors:  Masayuki Urabe; Tetsuo Ushiku; Aya Shinozaki-Ushiku; Akiko Iwasaki; Sho Yamazawa; Hiroharu Yamashita; Yasuyuki Seto; Masashi Fukayama
Journal:  Cancer Med       Date:  2018-09-21       Impact factor: 4.452

6.  Upper gastrointestinal cancer and reflux disease.

Authors:  Jin-Jo Kim
Journal:  J Gastric Cancer       Date:  2013-06-25       Impact factor: 3.720

7.  Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus.

Authors:  Danielle L Lavery; Pierre Martinez; Laura J Gay; Biancastella Cereser; Marco R Novelli; Manuel Rodriguez-Justo; Sybren L Meijer; Trevor A Graham; Stuart A C McDonald; Nicholas A Wright; Marnix Jansen
Journal:  Gut       Date:  2015-12-23       Impact factor: 23.059

8.  New Insights in Histogenetic Pathways of Gastric Cancer.

Authors:  Simona Gurzu; Haruhiko Sugimura; Janina Orlowska; Zoltan Szentirmay; Ioan Jung
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.